Scientific Programme
  Educational Sessions
  Plenary Sessions
  Oral Communications
  Scientific Symposia
  Satellite Symposia
Saturday, October 6
14:00 - 16:30 Educational sessions
14:00 - 15:00
First session
New oral anticoagulant treatments: the role of laboratory (Auditorium 1)
 Prof. Dr. Armando Tripodi
Prof. Dr. Meyer Michel Samama
Methology and statistics: How to interprete a clinical assay (Auditorium 2)
Prof. Dr. Patrick Mismetti
Life-threatening thrombosis and their treatment (Auditorium 3)
Dr. Charles Marc Samama
15:30 - 16:30
Second session
Which antiplatelet agent for whom? (Auditorium 1)
Dr. Ariel Cohen
Formation of the clot (Auditorium 2)
Dr. Bruce Furie
Circulating biomarkers (Auditorium 3)
Prof. Lina Badimon
16:30 - 17:00 Break
17:00 - 18:15 Opening ceremony (Auditorium 1)
17:00 - 17:30 Welcome
17:30 - 18:15
Plenary Lecture
The origins of mediterranean population determined by molecular anthropology
Dr. Jacques Chiaroni
18:30 - 19:30
Concert
Title: Canto General
Orchestra and choirs: Les Chants de Thau
Poems: Pablo Neruda Music: Mikis Theodorakis
19:30 - 21:00 Welcome Cocktail
Sunday, October 7
8:30 - 9:45
Plenary session (Auditorium 1)
8:30-9:10 Mechanisms of variability in antiplatelet agents response
Prof. Marco Cattaneo
9:10-9:45 New antiplagents agents: the end of resistance?
Prof. Dr. Adnan Kastrati
10:00 - 11:00 Oral communications
11:00 - 11:30 Break
11:30 - 12:40 Scientific Symposia
Thrombosis after surgical procedures (Auditorium 1)
 
Asymptomatic distal DVT is not a surrogate end-point
Dr. Charles Marc Samama
Bleeding definitions in orthopaedic VTE prophylaxis trials: a real need for standardization.
Prof. Dr. Ola E. Dahl
Should we follow the 9th ACCP guidelines?
Prof. Juan Ignacio Arcelus Martínez
Thrombosis and cancer: prevention and treatment (Auditorium 2)
 
Aspirin and colorectal cancer
Dr. Christophe Dubois

Multiple myeloma: epidemiology and risk factors
Dr. Xavier Leleu

Thrombosis during myeloma: prevention and treatment
Prof. Grégoire Le Gal
Unusual thrombosis sites (Auditorium 3)
 
Cerebral venous thrombosis, pregnancy and contraception.
Prof. Marie-Germaine Bousser
Splanchnic thrombosis
Dr. Walter Ageno
Mondor disease
Dr. Jean-Pierre Laroche
12:45 - 14:15
Satellite Symposia
14:15 - 15:30 Plenary Session (Auditorium 1)
 
14:15-14:50 New oral anticoagulant treatments in deep vein thrombosis
Dr. Pierre Fontana
14:50-15:30 Thrombosis in hematologic malignancies
Dr. Anna Falanga

15:30 - 16:15 Posters Session
Monday, October 8
8:30 - 9:45 Scientific Symposia
Women's health (Auditorium 1)
 
Estrogens, progestins, estrogenicity and new contraceptions
Dr. Regine Sitruk-Ware
Contraception, venous thrombosis and biological plausability
Dr. Geneviève Plu-Bureau
Estrogens and cardiovascular risk in menopausal women: benefit or harm? 
Prof. Jean-François Arnal
Thrombosis in patients with hemorrhagic disorder (Auditorium 2)
 
Thrombosis during PTI 
Prof. Mette Nørgaard
Thrombosis in factor VII deficiency
Prof. Muriel Giansily Blaizot
Thrombosis in haemophiliacs
Dr. Cedric Hermans
Surgery in hemophiliacs: is thromboprophylaxis mandated?
 Dr. Margareth Castro-Ozelo
Microparticules (Auditorium 3)
 
Microparticles in  vascular disorders
Dr. Rienk Niewland
Microparticles, endothelial dysfunction and atherothrombosis
Dr. Chantal Boulanger
Microparticles, angiogenesis and cancer David Varon
Prof. Dr. David Varon
10:00 - 11:00 Oral communications
11:00 - 11:30 Break
11:30 - 12:40 Plenary session (Auditorium 1)
 
11:30-12:10 Tissue factor and cancer
Prof. Wolfram Ruf
12:10-12:40 New insights in atrial fibrillation
 Prof. Dr. Jean-Yves Le Heuzey
12:45 - 14:00 Satellite Symposia
14:00 - 15:00 Posters session
15:00 - 16:30 Oral communications
16:30 - 17:00 Break
17:00- 18:20 Plenary session (Auditorium 1)
 
17:00-17:40 New insights into the contact activation system
Prof. Dr. Thomas Renné

17:40-18:20 Angiogenesis
Prof. Dr. Augustin Hellmut
18:30 - 19:45 Satellite Symposia
  GALA DINNER
Tuesday, October 9
8:30 - 9:45 Scientific Symposia
Antiphospholipid antibodies (Auditorium 1)
 
ISTH Guidelines
Dr. Vittorio Pengo
Anti beta2 glycoprotein antibodies: are they pathogen?
 Dr. Bas de Latte
Antiphospholipid antibodies: evaluation of the thrombotic risk
Dr. Katrien Devreese
Drug-induced thrombosis (Auditorium 2)
 
Adjuvant therapy for Breast cancer and thrombosis
Dr. Mario Mandala
Oral contraception in women with mild thrombophilia: what we've learned recently?
Dr. Ángeles Blanco Molina
Thrombotic risk and antipsychotics
Prof. Dr. Francis Couturaud
Antithrombotic agents and invasive procedures (Auditorium 3)
 

Cardiologist point of view
Dr. Jean-Philippe Collet
Anesthesiologist point of view
Dr. Pierre Albaladejo
Hematologist point of view
Prof. Thomas Lecompte
10:00 - 11:00 Oral communications
11:00 - 11:30 Break
11:30 - 12:40 Plenary session (Auditorium 1)
 
11:30-12:05 What did we learn from new oral anticoagulant treatment?
Dr. Charles T. Esmon
12:05-12:40 Endothelial progenitor cells and therapeutic angiogenesis
Dr. Jean-Sébastien Silvestre
12:45 - 14:00 Satellite Symposia
14:00 - 15:00 Posters session
15:00 - 16:30 Oral communications